Dunstan is currently Business Director at Plaxica, a spinout company based in London, founded in 2009 focused on the development of next generation of biopolymers.
Prior to joining Plaxica, Dunstan was Director, Intellectual Property & Licensing, at Thiakis, a biotech company focused on obesity and metabolic disease, where he was responsible for all aspects of global intellectual property strategy. He was integrally involved in all business development activities, including Thiakis’ £10m Series A Financing in 2006, and which culminated in the sale of the company to Wyeth for up to US$150m in 2008.
Previously Dunstan was a Technology Executive at Imperial Innovations, the AIM-listed technology transfer, investment and incubation company.